PRESS RELEASE published on 05/19/2025 at 08:30, 1 year 3 months ago Inside Information / Other news releases Arkema strengthens its refrigerant solutions with lower global warming potential offerings through a partnership with Honeywell. The expanded Forane® portfolio includes R-454B, R-448A, R-449A, R-452A, and R-513A Partnership ARKEMA Honeywell Refrigerant Global Warming Potential
PRESS RELEASE published on 05/19/2025 at 08:30, 1 year 3 months ago Informations privilégiées / Autres communiqués Arkema renforce son offre de réfrigérants à faible PRG en partenariat avec Honeywell pour répondre à la demande croissante de solutions éco-responsables dans l'industrie de la CVC-R Refrigerants ARKEMA Honeywell CVC-R Faible PRG
BRIEF published on 05/12/2025 at 15:46, 1 year 3 months ago Arkema annonce une mise à jour de ses actions et de ses droits de vote Actions Transparence Droit De Vote Conformité Réglementaire ARKEMA
BRIEF published on 05/12/2025 at 15:46, 1 year 3 months ago Arkema Announces Share and Voting Rights Update Voting Rights Shares Regulatory Compliance Transparency ARKEMA
PRESS RELEASE published on 05/12/2025 at 15:41, 1 year 3 months ago Informations privilégiées / Autres communiqués Déclaration réglementée du 12 mai 2025 concernant le nombre total de droits de vote et d'actions. Détails des chiffres liés aux droits de vote et aux actions Droits De Vote Code De Commerce Actions Déclaration Réglementée 12 Mai 2025
PRESS RELEASE published on 05/12/2025 at 15:41, 1 year 3 months ago Inside Information / Other news releases Press release about the statement regarding the number of shares and voting rights in compliance with the French commercial code and Financial Markets Authority regulations Voting Rights French Commercial Code Shares AMF Regulated Information
BRIEF published on 05/06/2025 at 11:51, 1 year 4 months ago Arkema Announces Share Buyback on May 2, 2025 Share Buyback Stock Market Financial Strategy 2025 ARKEMA
BRIEF published on 05/06/2025 at 11:51, 1 year 4 months ago Arkema annonce un rachat d'actions le 2 mai 2025 Rachat D'actions Stratégie Financière Bourse 2025 ARKEMA
PRESS RELEASE published on 05/06/2025 at 11:46, 1 year 4 months ago Informations privilégiées / Autres communiqués Déclaration des transactions sur actions propres réalisées par Arkema le 02 mai 2025 conformément à la réglementation en vigueur Actions Propres Transactions Réglementation Achats D'actions ARKEMA
PRESS RELEASE published on 05/06/2025 at 11:46, 1 year 4 months ago Inside Information / Other news releases Arkema discloses trading in own shares from 02 May to 02 May 2025 in accordance with EU regulations. For more details, visit the Arkema website Shares Trading Disclosure EU Regulations ARKEMA
Published on 09/10/2026 at 22:25, 12 hours 35 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 40 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 45 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 40 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 55 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 30 minutes ago Availability of the 2026 Interim Financial Report
